liv2666-sup-0001-figureS1.docxWord document13KFig. S1. The expression of SphK1 in liver cancer cells.
liv2666-sup-0002-figureS2.docxWord document13KFig. S2. SphK1 can promote HCC cell migration and invasion.
liv2666-sup-0003-figureS3.docxWord document13KFig. S3. phK1 inhibition can suppress HCC cell migration and invasion.
liv2666-sup-0004-figureS4.docxWord document13KFig. S4. S1P has no significant effect on liver cancer cell proliferation.
liv2666-sup-0005-figureS5.docxWord document13KFig. S5. Sphingosine-1-phosphate promotes liver cancer cell migration and invasion via EDG1.
liv2666-sup-0006-figureS6.docxWord document13KFig. S6. Expression of EDG1 is up-regulated in HCC patients.
liv2666-sup-0007-figureS7.docxWord document13KFig. S7. JTE-013 has no effect on liver cancer cells migration and invasion.
liv2666-sup-0008-tableS1.docxWord document13KTable S1. The clinic pathological features of 50 patients studied.
liv2666-sup-0009-tableS2.docxWord document13KTable S2. Primer sequences used for PCR.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.